Bioequivalence study of a novel Solutab® tablet formulation of amoxicillin/clavulanic acid versus the originator film-coated tablet

International Journal of Clinical Pharmacology and Therapeutics

Volumn 39, Issue 2, 2001, Pages 75-82

  Sourgens, H ^a   Steinbrede, H ^a   Verschoor, J S C ^a   Bertola, M A ^a   Rayer, B ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Amoxicillin clavulanic acid; Bioequivalence; Intra and intersubject variability

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CAFFEINE; CLAVULANIC ACID; GLUCOSE; NEW DRUG; POLYPROPYLENE; SOLUTAB; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SAFETY; FEMALE; FILM COATING; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; STATISTICAL ANALYSIS; TABLET FORMULATION; TABLET PROPERTY; ULTRAVIOLET RADIATION; VOMITING;

EID: 0035108860     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/cpp39075     Document Type: Article

References (13)

1. Amoxicillin/clavulanic acid: A review of its antibacterial activity, pharmacokinetics and therapeutic use
2. Comparative evaluation of orally active antibiotics against community-acquired pathogens: Results of eight European countries
3. Pharmacokinetic properties of β-lactamase inhibitors
4. Sample size determination: Extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43
5. The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections
6. Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin
7. Trends in the activity of macrolide and β-lactam antibiotics and resistance development
8. Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use
9. Multiple-dose bioequivalence study with josamycin propionate, a drug with highly variable kinetics, in healthy volunteers
10. Bioequivalence of a novel amoxicillin/clavulanate chewable tablet formulation
11. The penetration of amoxicillin/clavulanic acid into peritoneal fluid